Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke.
G J
GJ
del Zoppo
R
R
von Kummer
G F
GF
Hamann
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000098:blood supply*; D001929:Brain Edema / Q000139:chemically induced*; D002545:Brain Ischemia / Q000139:chemically induced*; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D008833:Microcirculation / Q000187:drug effects; D012307:Risk Factors; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects*
D010959:Tissue Plasminogen Activator